Biogated mesoporous silica nanoagents for inhibition of cell migration and combined cancer therapy
- 13 May 2024
- journal article
- research article
- Published by Springer Nature in Microchimica Acta
- Vol. 191 (6) , 1-9
Abstract
Migration is an initial step in tumor expansion and metastasis; suppressing cellular migration is beneficial to cancer therapy. Herein, we designed a novel biogated nanoagents that integrated the migration inhibitory factor into the mesoporous silica nanoparticle (MSN) drug delivery nanosystem to realize cell migratory inhibition and synergistic treatment. Antisense oligonucleotides (Anti) of microRNA-330-3p, which is positively related with cancer cell proliferation, migration, invasion, and angiogenesis, not only acted as the locker for blocking drugs but also acted as the inhibitory factor for suppressing migration via gene therapy. Synergistic with gene therapy, the biogated nanoagents (termed as MSNs-Gef-Anti) could achieve on-demand drug release based on the intracellular stimulus-recognition and effectively kill tumor cells. Experimental results synchronously demonstrated that the migration suppression ability of MSNs-Gef-Anti nanoagents (nearly 30%) significantly contributed to cancer therapy, and the lethality rate of the non-small-cell lung cancer was up to 70%. This strategy opens avenues for realizing efficacious cancer therapy and should provide an innovative way for pursuing the rational design of advanced nano-therapeutic platforms with the combination of cancer cell migratory inhibition. Graphical abstractKeywords
Funding Information
- the national key Research and Development Program of China (2018YFA0901300)
- The National Natural Science Foundation of China (22078149)
- Natural Science Foundation of Jiangsu Province (BK20220002)
- the Postgraduate Research and Practice Innovation Program of Jiangsu Province (CX10291)
This publication has 29 references indexed in Scilit:
- Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancerCell Death & Disease, 2020
- High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinomaOncogene, 2020
- The biomedical potential of cellulose acetate/polyurethane nanofibrous mats containing reduced graphene oxide/silver nanocomposites and curcumin: Antimicrobial performance and cutaneous wound healingInternational Journal of Biological Macromolecules, 2020
- Hypoxia-induced exosomes promote hepatocellular carcinoma proliferation and metastasis via miR-1273f transferExperimental Cell Research, 2019
- Trends in the development of miRNA bioinformatics toolsBriefings in Bioinformatics, 2018
- Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responsesPLOS ONE, 2018
- Surviving at a Distance: Organ-Specific MetastasisTrends in Cancer, 2015
- Tumour invasion and metastasis initiated by microRNA-10b in breast cancerNature, 2007
- Cell migration in tumorsCurrent Opinion in Cell Biology, 2005
- Cell Migration: A Physically Integrated Molecular ProcessCell, 1996